International Cannabis Weekly: 395

ITALIAN GOVERNMENT PUSHES HEMP FLOWER BAN USING EMERGENCY POWERS

The final nail in the coffin of Italy’s booming ‘cannabis light’ sector appears to have been hammered into place by the government, after months of the industry battling for its survival.

READ MORE  »

PHCANN NAMED HEADLINE SPONSOR OF CANNABIS EUROPA LONDON 2025

READ MORE »

CANNABIS INDUSTRY SUPPLY CHAIN ALREADY FEELING EFFECTS OF TRUMP’S TARIFFS

READ MORE »

• Austria has ruled out cannabis tourism despite growing signs of regional relaxation.
• Malta has proposed new amendments to tighten its recreational cannabis legislation.
• Medicinal cannabis in Flintshire, Wales, will be protected from discrimination by a local council.
• Germany’s cannabis reform: what’s changed one year after partial legalisation?
• Vaporised cannabis significantly improves symptoms in multiple sclerosis patients, study shows.
• Why the man behind the global success of Epidyolex is betting on Ananda Pharma.

PRE-REGISTER INTEREST »

• Maryland passes a new bill shielding minor cannabis convictions from public view.
• FDA hammered by lawmakers on Capitol Hill for allowing intoxicating hemp industry to flourish.
• Cannabis industry looks to target Trump with a new US$1 million ad push urging for reform.
• New Delaware bill seeks to resolve FBI dispute delaying adult-use cannabis rollout.
• Pennsylvania GOP senator backs cannabis legalisation to fund legacy investment fund.
• A judge has approved Minnesota cannabis rules, paving way for legal sales.

• Tilray has reported a decline in cannabis sales, lowering its 2025 forecast as a result.
• Legalisation has displaced the illicit cannabis market, according to Canadian research.
• HYTN has earned GMP certification for the US, Bermuda and Israel export markets.
• NFL-backed cannabinoid research trial enters next phase with Rapid Dose Therapeutics.
• Rubicon Organics has released its 2024 financial results, outlining new growth strategy.
• Nova Scotia has looked to authoris cannabis sales through Mi’kmaw communities.

• Bill which aims to regulate cannabis-based medicine production and sales discussed in Brazil.
• Ease Labs looks to produce the first domestically made cannabis capsules in Brazil.
• Panama introduces new framework to regulate access to medical cannabis products.
• Inside Paraguayan pressed cannabis: how it’s produced and the dangers it poses.

• Australian research has confirmed long-term cannabis relief for chronic conditions.
• NSW Drug Summit renews calls for reform of outdated cannabis driving laws in Australia.
• Cann Group has secured $712K in funding as share price dips in early trading session.
• One year on: medicinal cannabis shows real-world benefits for pain and mental health.

• South Africa health minister admits skipping consultation on cannabis food ban.
• Fighting for cannabis policy reform at the highest level in St. Vincent and the Grenadines.